Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
Chemo-Führerschein GYNÄKOLOGIE
Education
Willkommen zum Post-San Antonio-Podcast! Wir haben für Sie die wichtigsten Neuigkeiten vom größten Brustkrebskongress weltweit zusammengefasst. Welche Studien haben uns beeindruckt?
Frühes Mammakarzinom:
- INSEMA: Die in Deutschland initiierte Studie zeigte, dass die Sentinel node Biopsie bei Patientinnen > 50 J. mit T1 N0 G1-2 HR+ HER2- Tumoren keinen Vorteil bringt
- Gepar DOUZE: Kein Benefit durch den Immuncheckpointinhibitor Atezolizumab beim frühen triple-negativen Mammakarzinom
- EBCTCG-Metaanalyse: Die alleinige endokrine Therapie ist bei älteren Patientinnen mit einem hohen Risiko für Progression verbunden
Metastasiertes Mammakarzinom:
- PATINA: Hohe Effektivität von Palbociclib beim "triple-positiven" (HR+ HER2+) Mammakarzinom
- PRO-B: Tolle Studie aus Deutschland zu Patient-reported-outcomes! Eine App-basierte Erhebung der Lebensqualität verbesserte die Fatigue und das Überleben.
Hören Sie rein!
#chemofuehrerschein #sabcs24 #breastcancer #onkologie #weiterbildung
Create your
podcast in
minutes
It is Free